Skip to content

Application Research of Sub-voxel QSM Multi-component Quantitative Imaging and Texture Analysis Technology in Diagnosing and Staging Parkinson's Disease

Application Research of Sub-voxel QSM Multi-component Quantitative Imaging and Texture Analysis Technology in Diagnosing and Staging Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126507
Enrollment
Unknown
Registered
2026-06-10
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Gold Standard:The final diagnosis should comply with the "Diagnostic Criteria for Parkinson's Disease in China" established in 2016. Determining the diagnosis of parkinsonian syndrome is a prerequisit
(2) levodopa-induced dyskinesia occurs
(3) resting tremor is observed in a single limb during clinical examination
(4) auxiliary examinations: 'olfactory reduction or loss,' or 'cranial ultrasound shows abnormally high echogenicity in the substantia nigra (>20 mm²),' or cardiac iodine-123-metaiodobenzylguanidine s
Index test:Multiparametric Imaging Diagnostic Model

Sponsors

Fuzhou University Affiliated Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients suspected of Parkinson's disease and Parkinsonian syndromes were collected based on clinical data, and those whose final diagnosis met the "Diagnostic Criteria for Parkinson's Disease in China" formulated by the Neurology Branch of the Chinese Medical Association in 2016 were included. 2. Control group: 30 healthy volunteers were included, with no history of severe mental disorders, no history of neurodegenerative diseases, trauma, or tumors. No contraindications for MRI examination, etc.

Exclusion criteria

Exclusion criteria: 1. Parkinsonism overlap syndrome includes Alzheimer's disease, vascular dementia, and psychiatric disorders; 2. Patients who have not completed clinical scales; 3. Poor compliance with MRI examination or contraindications to MRI, such as having a cardiac pacemaker, artificial cochlea, metallic foreign body in the eye, claustrophobia, pregnancy, etc.; 4. Poor MRI image quality, such as severe tremor, dyskinesia, or difficulty analyzing QSM images.

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy;

Secondary

MeasureTime frame
Sensitivity;specificity;positive predictive value;negative predictive value;

Countries

China

Contacts

Public ContactLin Shengmei

Fuzhou University Affiliated Provincial Hospital

295237790@qq.com+86 591 8821 6266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026